Platelet and plasma platelet-activating factor in sepsis and myocardial infarction.

Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. J Clin Invest (1999) 1.02

In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin. J Inflamm (Lond) (2011) 0.77

Platelet and plasma platelet-activating factor in sepsis and myocardial infection. J Lipid Mediat Cell Signal (1994) 0.75

PAF and human cardiovascular disorders. J Lipid Mediat Cell Signal (1995) 0.75

A community-based study of chronic fatigue syndrome. Arch Intern Med (1999) 6.04

Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res (2001) 3.29

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation (1997) 2.80

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res (2000) 2.79

Severe late postsplenectomy infection. Br J Surg (1991) 2.15

Relative cost-effectiveness of a skin protectant in managing venous leg ulcers in the UK. J Wound Care (2012) 2.06

Improved analysis of brachial artery ultrasound using a novel edge-detection software system. J Appl Physiol (1985) (2001) 2.02

Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation (1997) 1.64

Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. J Antimicrob Chemother (1998) 1.60

Oxidant stress induces gamma-glutamylcysteine synthetase and glutathione synthesis in human bronchial epithelial NCI-H292 cells. Clin Exp Allergy (2002) 1.55

Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. J Clin Invest (1969) 1.52

Dependence of ventricular distensibility on filling of the opposite ventricle. Am J Physiol (1967) 1.33

Diastolic geometry and sarcomere lengths in the chronically dilated canine left ventricle. Circ Res (1971) 1.32

Left ventricular function in experimental aorto-caval fistula with circulatory congestion and fluid retention. J Clin Invest (1968) 1.22

Modification of forearm resistance vessels by exercise training in young men. J Appl Physiol (1985) (1994) 1.21

Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer (2001) 1.16

Chronic fatigue syndrome: occupation, medical utilization, and subtypes in a community-based sample. J Nerv Ment Dis (2000) 1.16

Congestive heart failure following chronic tachycardia. Am Heart J (1971) 1.15

Regression of left ventricular dilation and hypertrophy after removal of volume overload. Morphological and ultrastructural study. Circ Res (1974) 1.12

Influence of the thyroid state on left ventricular tension-velocity relations in the intact, sedated dog. J Clin Invest (1969) 1.12

p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2. Cancer Res (2001) 1.11

Control of skeletal muscle blood flow during dynamic exercise: contribution of endothelium-derived nitric oxide. Sports Med (1996) 1.09

A quantitative analysis of left ventricular myocardial function in the intact, sedated dog. Circ Res (1967) 1.09

Endothelium-derived nitric oxide activity in forearm vessels of tennis players. J Appl Physiol (1985) (1996) 1.08

A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1. Oncogene (2010) 1.06

Differential antibody recognition of FC27-like Plasmodium falciparum merozoite surface protein MSP2 antigens which lack 12 amino acid repeats. Parasite Immunol (1996) 1.05

Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms. Psychosom Med (2001) 1.04

Biochemical diversity within the "Mycoplasma mycoides" cluster. Microbiology (1994) 1.03

Efficacy of the latest fluoroquinolones against experimental Yersinia pestis. Int J Antimicrob Agents (2004) 1.03

Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases. J Control Release (2006) 1.02

Oxygen uptake and H2O2 production by fermentative Mycoplasma spp. J Med Microbiol (1991) 1.02

Measurement of myocardial developed tension and its relation to oxygen consumption. Am J Physiol (1966) 1.00

Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis. Crit Care Med (1994) 1.00

Physical factors and cardiac adaptation. Am J Physiol (1966) 0.98

Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. J Cardiovasc Risk (2001) 0.97

Collision of uterine rhabdoid tumor and endometrioid adenocarcinoma: a case report and review of the literature. Int J Gynecol Pathol (1999) 0.95

Nitric oxide-dependent endothelial function is unaffected by allopurinol in hypercholesterolaemic subjects. Clin Exp Pharmacol Physiol (1999) 0.95

Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes. Am J Physiol (1999) 0.95

Chronic fatigue syndrome: sociodemographic subtypes in a community-based sample. Eval Health Prof (2000) 0.95

Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas. Gynecol Oncol (1997) 0.94

Mammalian Scratch: a neural-specific Snail family transcriptional repressor. Proc Natl Acad Sci U S A (2001) 0.93

Loss of a single Hic1 allele accelerates polyp formation in Apc(Δ716) mice. Oncogene (2011) 0.93

Volume-tension diagrams of ejecting and isovolumic contractions in left ventricle. Am J Physiol (1969) 0.92

Symptom occurrence in persons with chronic fatigue syndrome. Biol Psychol (2002) 0.92

PGE 2 and dibutyryl cyclic adenosine monophosphate prolong eosinophil survival in vitro. J Allergy Clin Immunol (1999) 0.91

Attitudes regarding chronic fatigue syndrome: the importance of a name. J Health Psychol (2001) 0.90

Assessing attitudes toward new names for chronic fatigue syndrome. Eval Health Prof (2001) 0.90

Active length-tension relations compared in isometric, afterloaded and isotonic contractions of cat papillary muscle. Their dependence on inotropic state. Circ Res (1970) 0.90

Monitoring and assessing symptoms of chronic fatigue syndrome: use of time series regression. Psychol Rep (1999) 0.90

Effect of beta-adrenergic blockade on the results of exercise testing related to the extent of coronary artery disease. Am J Cardiol (1985) 0.89

Effects of chelation with EDTA and vitamin B therapy on nitric oxide-related endothelial vasodilator function. Clin Exp Pharmacol Physiol (1999) 0.88

The series elasticity of cardiac muscle in hyperthyroidism, ventricular hypertrophy, and heart failure. Proc Soc Exp Biol Med (1968) 0.88

Primary angiosarcoma of the ovary: a case report and review of the literature. Gynecol Oncol (1999) 0.88

A national assessment of the service, support, and housing preferences by persons with chronic fatigue syndrome. Toward a comprehensive rehabilitation program. Eval Health Prof (1996) 0.87

Theoretical analysis of the isovolumic phase of left ventricular contraction in terms of cardiac muscle mechanics. Cardiovasc Res (1970) 0.87

Feminist perspectives on the social construction of chronic fatigue syndrome. Health Care Women Int (2001) 0.86

Protein synthesis during right-ventricular hypertrophy after pulmonary-artery stenosis in the dog. Biochem J (1977) 0.86

Comparison of vasodilator drug prazosin with digoxin in aortic regurgitation. Br Heart J (1980) 0.86

The effect of homocysteine on DNA synthesis in cultured human vascular smooth muscle. Atherosclerosis (1998) 0.85

Chronic fatigue syndrome: an examination of the phases. J Clin Psychol (2000) 0.85

Molecular characterization of adenocarcinoma of the cervix. Gynecol Oncol (1997) 0.85

Relationships between left ventricular volume, ejected fraction, and wall stress. Am J Physiol (1966) 0.85

Influence of sodium bicarbonate on myocardial performance. Am J Physiol (1967) 0.85

Contractile properties of cardiac muscle in hyperthyroidism. Analysis of behavior of hyperthyroid cat papillary muscle in vitro relevant to thyrotoxic heart disease. Circ Res (1970) 0.85

Early changes in myocardial protein synthesis in vivo in response to right ventricular pressure overload in the dog. J Mol Cell Cardiol (1979) 0.85

Cystoscopy after computed tomography scan to identify bladder invasion in cervical cancer. Obstet Gynecol (1998) 0.84

Cigarette smoking and ventricular arrhythmia in coronary heart disease. Am J Cardiol (1984) 0.84

Mammalian Scratch participates in neuronal differentiation in P19 embryonal carcinoma cells. Brain Res Mol Brain Res (2001) 0.84

Platelet-activating factor and lipid metabolism in acute malaria. J Infect (1993) 0.84

Developmental analysis and computer modelling of bioengineered teeth. Arch Oral Biol (2005) 0.83

Myocardial digoxin uptake in pressure overload right ventricular hypertrophy. Cardiovasc Res (1974) 0.83

Premature ischaemic heart disease and the gene for coagulation factor V. Nat Med (1995) 0.83

Beta-adrenergic blockade in the treatment of exercise-induced paroxysmal ventricular tachycardia. Circulation (1965) 0.83

Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation (1995) 0.83

Oncostatin M synergises with house dust mite proteases to induce the production of PGE(2) from cultured lung epithelial cells. Br J Pharmacol (2000) 0.82

Influence of various catecholamines on aortic regurgitation. J Appl Physiol (1973) 0.82

Costs and outcomes over 36 years of patients with phenylketonuria who do and do not remain on a phenylalanine-restricted diet. J Intellect Disabil Res (2012) 0.82

Glutathione peroxidase activity and mRNA expression in eosinophils and neutrophils of asthmatic and non-asthmatic subjects. J Leukoc Biol (1998) 0.81

Influence of myocardial mechanical activity and coronary blood flow on myocardial digoxin uptake. Cardiovasc Res (1976) 0.81

Age dependence of myocardial Na+-K+-ATPase activity and digitalis intoxication in the dog and guinea pig. Circ Res (1981) 0.81

The measurement of plasma thromboxane B2 and the effect of smoking. Clin Exp Pharmacol Physiol (1985) 0.80

Effect of casting on forearm resistance vessels in young men. Med Sci Sports Exerc (1997) 0.80

Apolipoprotein epsilon 4 homozygosity--a determinant of restenosis after coronary angioplasty. Atherosclerosis (1994) 0.80

Digitalis-induced increase in aortic regurgitation and the contrasting effect of glucagon in the sedated dog. J Clin Invest (1974) 0.80

The effect of heart rate on myocardial ouabain uptake and on the susceptibility to ouabain cardiotoxicity in the dog. Clin Exp Pharmacol Physiol (1978) 0.80

p27 and cyclin D1 abnormalities in uterine papillary serous carcinoma. Gynecol Oncol (2000) 0.80

PIa1/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty. Am J Cardiol (1998) 0.80

Hypoxemia after gastric bypass surgery for morbid obesity. Arch Surg (1985) 0.79

Beneficial effect of vitamin E administration on nitric oxide function in subjects with hypercholesterolaemia. Clin Sci (Lond) (1998) 0.79

Headspace/solid-phase microextraction/gas chromatography-mass spectrometry: a screening technique for the recovery and identification of volatile organic compounds (VOC's) in postmortem blood and viscera samples. J Forensic Sci (2001) 0.79

Effect of chronic circulatory volume overload on digitalis intoxication. Cardiovasc Res (1973) 0.79

Familial hypertrophic cariomyopathy and lentiginosis. Aust N Z J Med (1975) 0.79

Plasma phospholipase A2 activity in clinical acute myocardial infarction. Clin Exp Pharmacol Physiol (1992) 0.79

Variation in plasma platelet-activating factor degradation and serum lipids after acute myocardial infarction. Coron Artery Dis (1993) 0.78

Alopecia areata regrowth induced by Primula obconica. Br J Dermatol (1981) 0.78

Dietary fish oils reduce plasma levels of platelet activating factor precursor (lyso-PAF) in rats. Life Sci (1986) 0.78

Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels. J Clin Endocrinol Metab (1996) 0.78